Literature DB >> 31421429

Hypothesis: Mechanism of irritable bowel syndrome in inflammatory bowel disease.

Yoshiharu Uno1.   

Abstract

Functional bowel symptoms can be occurred during remission from inflammatory bowel disease. In this case, a low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet is effective for the amelioration or prevention of symptoms. However, the reason is not fully explained. This report proposes a hypothesis regarding the entire process in which inflammatory bowel disease with IBS-like symptoms (IBD-IBS) causes symptoms. A detailed process was assumed, starting from high pressure in the lumen and finally to abdominal symptoms. In this process, relationships were linked based on interactions such as ischemia, compliance, pain threshold, visceral hypersensitivity, mast cells, and permeability reported in IBD-IBS. In the process mapping, to understand the relationship between the amount of gas increased by FODMAP and ischemia, the hydrodynamic hypothesis and Ritchie's hypothesis were adapted. Ischemia in dilated intestines due to an increase in gas volume can induce excessive spasms via the mast cells and show the whole process of lowering the pain threshold. From the standpoint of the mechanism of IBD-IBS, the origin trigger may be FODMAP. Therefore, a low-FODMAP diet is recommended to relieve and prevent IBD-IBS symptoms.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  FODMAP; Inflammatory bowel disease; Irritable bowel syndrome; Ischemia; Mast cell

Mesh:

Substances:

Year:  2019        PMID: 31421429     DOI: 10.1016/j.mehy.2019.109324

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  6 in total

1.  The CCL28 levels are elevated in the serum of patients with irritable bowel syndrome and associated with the clinical symptoms.

Authors:  Farshad Sheikhesmaili; Ali Jalili; Elmira Taghizadeh; Shohreh Fakhari; Khashaiar Jalili; Ebrahim Ghaderi; Ezatollah Rahimi
Journal:  Am J Clin Exp Immunol       Date:  2021-02-15

2.  Effects of Commercial Probiotics on Colonic Sensitivity after Acute Mucosal Irritation.

Authors:  Laura López-Gómez; Jaime Antón; Yolanda López-Tofiño; Bianca Pomana; José A Uranga; Raquel Abalo
Journal:  Int J Environ Res Public Health       Date:  2022-05-26       Impact factor: 4.614

3.  Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management.

Authors:  Martina Ledergerber; Brian M Lang; Henriette Heinrich; Luc Biedermann; Stefan Begré; Jonas Zeitz; Niklas Krupka; Andreas Rickenbacher; Matthias Turina; Thomas Greuter; Philipp Schreiner; René Roth; Alexander Siebenhüner; Stephan R Vavricka; Gerhard Rogler; Niko Beerenwinkel; Benjamin Misselwitz
Journal:  BMC Gastroenterol       Date:  2021-02-05       Impact factor: 3.067

4.  Xi Lei San Attenuates Dextran Sulfate Sodium-Induced Colitis in Rats and TNF-α-Stimulated Colitis in CACO2 Cells: Involvement of the NLRP3 Inflammasome and Autophagy.

Authors:  Zhang Tao; Xiaoqing Zhou; Yan Zhang; Wenfeng Pu; Yi Yang; Fuxia Wei; Qian Zhou; Lin Zhang; Zhonghan Du; Ji Wu
Journal:  Mediators Inflamm       Date:  2021-04-21       Impact factor: 4.711

5.  Secondary Dysfunction of the Intestinal Barrier in the Pathogenesis of Complications of Acute Poisoning.

Authors:  Ju Ju Ivnitsky; T V Schäfer; V L Rejniuk; O A Vakunenkova
Journal:  J Evol Biochem Physiol       Date:  2022-08-28       Impact factor: 1.621

Review 6.  Mast Cell Regulation and Irritable Bowel Syndrome: Effects of Food Components with Potential Nutraceutical Use.

Authors:  José Antonio Uranga; Vicente Martínez; Raquel Abalo
Journal:  Molecules       Date:  2020-09-20       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.